Clinical Trial Update: Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

This clinical trial is evaluating Pueraria lobata radix as an adjuvant therapy for Type 2 diabetes mellitus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Pueraria Lobata Radix (Pueraria lobata radix)

Snippet

Sponsor: Jiangxi University of Traditional Chinese Medicine | Conditions: Type 2 Diabetes Mellitus | NA | Status: RECRUITING